Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

NCT03647982 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

NCT02601287 ·Status: COMPLETED ·Phase: PHASE4

Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB)

NCT02735499 ·Status: COMPLETED ·Phase: PHASE2

BOTOX® at the Time of Prolapse Surgery for OAB

NCT04807920 ·Status: UNKNOWN ·Phase: PHASE4

Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction

NCT01220726 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder.

NCT00231491 ·Status: COMPLETED ·Phase: PHASE2

Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

NCT01042119 ·Status: COMPLETED

BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence

NCT03320850 ·Status: COMPLETED ·Phase: PHASE2

Minimizing Pain During Office Intradetrussor Botox Injection

NCT04270526 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00311376 ·Status: COMPLETED ·Phase: PHASE3

PTNS vs Botox of Refractory OAB

NCT04451382 ·Status: TERMINATED

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.

NCT00479596 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

NCT00461292 ·Status: COMPLETED ·Phase: PHASE3

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

NCT05968885 ·Status: RECRUITING ·Phase: PHASE4

A Research Study for Patients With Overactive Bladder

NCT00168454 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder

NCT02161159 ·Status: COMPLETED

Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea

NCT02010788 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

NCT01767519 ·Status: COMPLETED ·Phase: PHASE3

516-BOTOX Urinary Incontinence Detrusor

NCT00850733 ·Status: COMPLETED

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

NCT01945489 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB)

NCT02786407 ·Status: UNKNOWN ·Phase: PHASE3

A Multi-Center Trial of Botox for Severe Urge Urinary Incontinence

NCT00345332 ·Status: COMPLETED ·Phase: NA

Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence

NCT03052764 ·Status: COMPLETED ·Phase: PHASE4

Toxin Retrospective Study

NCT03042052 ·Status: COMPLETED

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

NCT00578097 ·Status: TERMINATED ·Phase: PHASE2